Company intelligence / Profile preview

MedPalett

Sandnes, Rogaland, Norway

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

MedPalett developed proprietary processes to extract and preserve anthocyanins from wild bilberries and blackcurrants. Their lead product, MEDOX®, has been subject to over 25 published clinical studies showing potential health benefits, particularly for cardiovascular health. The company’s extracts are used both in consumer supplements (MEDOX®) and as B2B ingredients (HEALTHBERRY®)

Therapeutic areas: OtherCardiovascularImmunology
Modalities: Natural product extractNutraceutical ingredient (Anthocyanins)
Industry: Food & Nutrition

Drug pipeline

2 assets

Medox

Commercial

Indications: General health

1 more asset in the full pipeline.

Request access →

Partnerships

Evonik Industries (acquirer/distribution partner)

Beyond the preview

Go deeper on MedPalett.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedPalett.

Explore the full profile